1. babyti7947
2. pennyegan987944
3. amyg6409
4. clmt995
5. 23shong
1.pennyegan987944 02/26/2018
Galapagos delivered in 2017
2.amyg6409 08/03/2018
Reports 1H EPS loss of €1.16 and revenue of €101.9M (+39.6% Y/Y)
3.clmt995 02/18/2018
Not sure it was worth the wait...news.
4.pennyegan987944 04/27/2018
Galapagos presents strong disease-modifying effects in preclinical model of osteoarthritis with GLPG1972 at OARSI 2018
5.babyti7947 10/23/2018
POSITIVE TRIAL RESULTS WITH FILGOTINIB IN PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS BOTH PUBLISHED IN THE LANCET
6.amyg6409 03/26/2018
Publication of the annual report and invitation to the annual shareholders' meeting
7.babyti7947 04/26/2018
Galapagos reports first quarter 2018 results
8.babyti7947 01/02/2018
Update on progress in cystic fibrosis programs
9.babyti7947 04/24/2018
Galapagos reports initiation of FALCON clinical trial in cystic fibrosis
10.clmt995 06/20/2018
Galapagos increases share capital through warrant exercises
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW